Cite
HARVARD Citation
Zanetto, A. et al. (n.d.). Prothrombotic microparticles and risk of portal vein thrombosis in patients with HCV-related liver cirrhosis who underwent DAA antiviral therapy. Digestive and liver disease. 49 (1), pp. e9-. [Online].